SCA
MTEM

SAC Capital Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

SAC Capital Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-87
Closed -$68K – 1135
2014
Q1 		$68K Sell
87
-21
-19% -$17.1K ﹤0.01% 1695
2013
Q4 		$83K Buy
108
+46
+74% +$34.7K ﹤0.01% 1724
2013
Q3 		$47K Buy
+62
New +$50.9K ﹤0.01% 1725

Other funds holding MTEM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAC Capital Advisors's MTEM Position: Q2 2014 in Review

SAC Capital Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2014, closing a stake of 87 shares — an estimated $68K sold.

SAC Capital Advisors first reported a position in MTEM in Q3 2013 and held it in 3 quarters. The position peaked at $83K in Q4 2013. 86 funds tracked by Wall St. Rank hold MTEM as of Q2 2014.

  • SAC Capital Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 87 Molecular Templates, Inc. shares in Q2 2014, an estimated $68K.
  • SAC Capital Advisors first reported a position in Molecular Templates, Inc. in Q3 2013 and held it in 3 quarters.
  • SAC Capital Advisors's Molecular Templates, Inc. position peaked at $83K in Q4 2013.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.